Actively Recruiting
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
Led by National Cancer Institute (NCI) · Updated on 2026-05-14
4000
Participants Needed
1
Research Sites
567 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: All childhood cancers are rare, but some are called very rare. Very rare cancers are diagnosed in 2 or fewer out of 1 million people each year. Researchers want to gather data so they can learn more about these very rare cancers. They hope to use the data to develop future treatments. Objective: To gather data for a registry of very rare cancers found in children, teens, and young adults. Eligibility: People aged 1 month to 39 years newly diagnosed (within the past year) with a very rare cancer. Design: Participation will be by phone or email. No clinic visits are required. Researchers will look at the participant s medical records. They will ask for samples of tumor tissue that were already removed. They will use the samples for genetic testing. The results of these tests will be sent to the participant s own doctors. Some participants will be asked for saliva or cheek swab samples. They will receive a kit in the mail. They will spit into a tube or swab the inside of their cheek. They will mail the sample back to the lab. Participants will fill out questionnaires once a year for 5 years. They will answer questions about: Family history, such as other cancers in the family and their income, work, and education. Demographics, such as their gender, nationality, ethnicity, education, and work history. Symptoms and treatment for their cancer. This may include level of pain, and emotional and physical well-being. Participants data will be added to a secure database for other researchers. Their data will be anonymous.
CONDITIONS
Official Title
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of newly diagnosed (within 1 year) very rare solid tumor (2 or fewer cases per million per year)
- Age 1 month to 39 years at diagnosis
- Established care with a local treating physician
- Ability and willingness of participant or guardian to sign informed consent
You will not qualify if you...
- Diagnosis of Ewing Sarcoma at any time
- Diagnosis of Osteosarcoma at any time
- Diagnosis of Rhabdomyosarcoma at any time
- Diagnosis of Diffuse midline glioma (H3K27 altered) at any time
- Diagnosis of Atypical teratoid rhabdoid tumor at any time
- Diagnosis of Pleuropulmonary blastoma at any time
- Diagnosis of common adult cancers in pediatric/AYA populations (e.g., colorectal, breast cancer)
- Unlikely to comply with protocol requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
M
Mary F Wedekind Malone, D.O.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here